Purchase Order 75N94020P00416
- Not listed
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $24,948.00 firm fixed price purchase order is for a complex lipid panel analysis of 56 samples. The contract has no set-aside designation. Metabolon is a leading provider of specialized metabolomics analysis services, leveraging its proprietary platforms to support a wide range of federal...
- The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), awarded a sole-source contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic analysis services. The $28,991.20 firm-fixed-price purchase order is to support the Liver Diseases Branch's research on microbiomes and their effects on host physiology and immune responses. Metabolon will use ultra-high performance liquid chromatography...
- This is a $40,500 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a study comparing patients with lipodystrophy to patients with insulin receptor mutations. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker...
- This is a $10,000.00 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Metabolon, Inc., a self-certified small disadvantaged business, for the metabolic analysis of duodenal aspirate samples. The award does not have a set-aside designation. Metabolon, a leading provider of metabolomics solutions, has served as both a prime contractor and subcontractor on numerous federal contracts and grants supporting research initiatives across various...
- This federal contract award to Metabolon, Inc., a self-certified small disadvantaged business, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $9,000 firm fixed-price purchase order does not have a set-aside designation. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. This award...
- This is a $226,695.00 firm fixed price purchase order awarded by the Northeast Area division of a civilian federal agency to Metabolon, Inc., a small disadvantaged business, for metabolomic profiling of plasma samples. The contract has a period of performance through May 15, 2024. Metabolon is a leading provider of metabolomics solutions and has served as a prime contractor on numerous federal contracts, supporting research initiatives across agencies like the VA, NIH, FDA, DoD, EPA, and USDA....
- This is a firm-fixed price purchase order awarded by the Department of Agriculture's Agricultural Research Service to Metabolon, Inc., a small disadvantaged business, for global metabolomics services. The contract has a potential value of $249,981.48 and a completion date of August 31, 2024. Metabolon provides specialized metabolomics analysis capabilities, including the identification and quantification of thousands of metabolites, to support biomedical research and regulatory science...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for the collection and analysis of 48 24-hour urine samples from a low-calorie-low-fat (LCLF) diet intervention study. Metabolon, a leading provider of metabolomics services, will leverage its proprietary analytical platforms to identify and quantify metabolites...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
- The U.S. government awarded a $31,500 firm fixed-price purchase order to Metabolon, Inc. for metabolic profile services on September 29, 2016, with a one-year completion date. The contract, issued by a civilian agency under the Northeast Area, did not utilize a set-aside designation. Metabolon, a self-certified small disadvantaged business headquartered in Morrisville, North Carolina, will perform the work at its Calverton, Maryland facility. The company specializes in metabolomics services,...
This is a federal contract award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business, for $21,600.00. The contract is for the acquisition of metabolic profiling of mouse livers. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. The company has served as both a prime contractor and subcontractor on numerous federal contracts and grants with agencies like the Department of Veterans Affairs (VA), National Institutes of Health (NIH), Food and Drug Administration (FDA), Department of Defense (DoD), Environmental Protection Agency (EPA), and Department of Agriculture (USDA). This contract is a firm fixed price purchase order with an ultimate completion date of August 28, 2020. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 6/9/20 |